Restructuring activities are essential to optimize the business operating model for GE HealthCare and mostly involve workforce reductions, organizational realignments, and revisions to our real estate footprint. Specifically, restructuring charges (gains) primarily include facility exit costs, employee-related termination benefits associated with workforce reductions, asset write-downs, and cease-use costs. For segment reporting, restructuring activities are not allocated.

Net expenses for restructuring initiatives committed to by management through March 31, 2025 are included in the table below.


	For the three months ended March 31
		2025		2024
Employee termination costs		$	21	$	25
Facility and other exit costs		—		8
Asset write-downs		1		7
Total restructuring activities – net		$	22	$	40

These restructuring initiatives are expected to result in additional expenses of approximately $40 million, to be incurred primarily over the next 12 months, substantially related to employee-related termination benefits and asset write-downs. Restructuring expenses (gains) are recognized within Cost of products, Cost of services, or SG&A, as appropriate, in the Condensed Consolidated Statements of Income.

Liabilities related to restructuring are recognized within Current compensation and benefits, All other current liabilities, Non-current compensation and benefits, and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. The activity related to our restructuring liabilities follows.


	Employee termination costs		Facility and other exit costs		Total




Balance at December 31, 2024	$	67	$	18	$	86
Charges	19		1		20
Payments and other adjustments	(14)		(3)		(17)
Balance at March 31, 2025	$	73	$	16	$	89